Search | Page 4 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. MDS expert finds promising antibody

    ... Researchers find new way to target blood stem cell cancers Article ... of leukemic stem cells become incapable of maturing into red or white blood cells as intended. Most leukemias respond initially to ...

    Article last updated 01/26/2017 - 1:14pm.

  2. Recent advances in the treatment of lower-risk non-del(5q) myelodysplastic syndromes (MDS)

    ... aim of treatment is to improve anemia and decrease red blood cell transfusions. For transfusion-dependent patients with lower-risk ...

    Research Article last updated 12/09/2016 - 2:50pm.

  3. Efficacy and Safety of Lenalidomide for Treatment of Low-/Intermediate-1-Risk Myelodysplastic Syndromes with or without 5q Deletion: A Systematic Review and Meta-Analysis

    ... Lenalidomide could effectively induce red blood cell (RBC) transfusion independence (TI) in patients with ...

    Research Article last updated 11/28/2016 - 9:36am.

  4. Alternative Donor Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Refractory Severe Aplastic Anemia

    ... Journal Title:  Biol Blood Marrow Transplant Primary ... for 3 consecutive days was 19 (range, 16 to 27) days, to red cell engraftment was 25 (range, 2 to 58) days, and to last ...

    Research Article last updated 01/24/2017 - 10:04am.

  5. Long-term follow-up of patients with moderate aplastic anemia and pure red cell aplasia treated with daclizumab.

    ... BACKGROUND: Pure red cell aplasia and moderate aplastic anemia are marrow failure ... Previously, we described short-term improvements in blood counts in two pilot studies treating moderate aplastic anemia (mAA) and ...

    Research Article last updated 10/11/2011 - 5:58pm.

  6. Special Precautions

    ... a good idea to: Check with your doctor Get a red blood cell count Get treatment for your anemia (blood transfusions or ...

    Topic section last updated 09/08/2017 - 12:34pm.

  7. Local TV covers AAMDSIF Peer Support Networker

    ... characterized the complement system destructing red blood cells to early. Red blood cells are missing the PIG-A gene that ...

    Article last updated 11/28/2016 - 3:21pm.

  8. Paroxysmal Nocturnal Hemoglobinuria: From Bench to Bed

    ... Journal Title:  Indian J Hematol Blood Transfus Primary Author:  ... of complement-mediated hemolysis in unprotected red cells, leukocytes, and platelets as well as the release of free ...

    Research Article last updated 11/28/2016 - 11:40am.

  9. Design and rationale of the QUAZAR Lower-Risk MDS (AZA-MDS-003) trial: a randomized phase 3 study of CC-486 (oral azacitidine) plus best supportive care vs placebo plus best supportive care in patients with IPSS lower-risk myelodysplastic syndromes and po

    ... and/or thrombocytopenia who may have required red blood cell or platelet transfusions. The overall response rate was ...

    Research Article last updated 06/23/2016 - 10:17am.

  10. Resources to Help

    ... all patients to receive bone marrow or umbilical cord blood transplant when needed. Patient Advocate Foundation/ Equal ... Nocturna Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) Feder Foundation: Spanish ...

    Topic section last updated 09/28/2017 - 11:58am.